Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for delayed sleep phase disorder
ACTRN12612000425897Phase 2Completed
- Sponsor
- Circadian Health Innovations
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in delayed sleep-wake phase disorder (DSPD) comparing Melatonin with Placebo (2 arms). Started Sep 2012; status: completed.
02
Drugs
melatonin
03
Conditions
delayed sleep-wake phase disorder (DSPD)
Beyond the preview
Go deeper on ACTRN12612000425897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000425897.